Articles published in Journal of AIDS & Clinical Research have been cited by esteemed scholars and scientists all around the world.
Journal of AIDS & Clinical Research has got h-index 29, which means every article in Journal of AIDS & Clinical Research has got 29 average citations.
Following are the list of articles that have cited the articles published in Journal of AIDS & Clinical Research.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
42 | 57 | 66 | 61 | 32 | 29 | 31 |
Research, Review articles and Editorials |
2 | 10 | 13 | 16 | 25 | 25 | 28 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
40 | 47 | 53 | 44 | 7 | 4 | 3 |
Conference proceedings |
0 | 0 | 14 | 8 | 0 | 75 | 60 |
Citations received as per Google Scholar, other indexing platforms and portals |
5226 | 4463 | 484 | 590 | 666 | 563 | 560 |
| Journal total citations count | 5061 |
| Journal impact factor | 2.8 |
| Journal 5 years impact factor | 10.46 |
| Journal cite score | 9.49 |
| Journal h-index | 29 |
| Journal h-index since 2019 | 21 |
Wood D. Advancements And Applications Of Nonstandard Finite Difference Methods. |
|
Dimitrov DT, Boily MC, Hallett TB, Albert J, Boucher C, Mellors JW, Pillay D, van de Vijver DA. How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact. PloS one. 2016 Jul 8;11(7):e0158620. |
|
Parikh UM, Mellors JW. Should We Fear Resistance from Tenofovir/Emtricitabine PrEP?. Current Opinion in HIV and AIDS. 2016 Jan;11(1):49. |
|
Srinivasan P, Moss JA, Gunawardana M, Churchman SA, Yang F, Dinh CT, Mitchell JM, Zhang J, Fanter R, Miller CS, Butkyavichene I. Topical delivery of tenofovir disoproxil fumarate and emtricitabine from pod-intravaginal rings protects macaques from multiple SHIV exposures. PloS one. 2016 Jun 8;11(6):e0157061. |
|
Pham QD, Wilson DP, Nguyen TV, Do NT, Truong LX, Nguyen LT, Zhang L. Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies. Journal of Antimicrobial Chemotherapy. 2016 Feb 10:dkv473. |
|
Phung TT, Phan CT, Khuc HT, Van Nguyen L, Le YT, Khu DT, Nguyen LT. Characterization of drug resistance mutations in ART-naïve HIV-1 infected children in Northern Vietnam. Asian Pacific Journal of Tropical Disease. 2015 Sep 1;5(9):691-4. |
|
Khan S. Asian Pacific Journal of Tropical Disease. |
|
Agneskog E. Assays for monitoring HIV therapy in low-middle income countries. Inst för laboratoriemedicin/Dept of Laboratory Medicine; 2013 May 20. |
|
DO DUY CU. Antiretroviral therapy among HIV-infected persons in Northeastern Vietnam. |
|
Do Duy C. Antiretroviral therapy among HIV-infected persons in Northeastern Vietnam: Impact of peer support on virologic failure and mortality in a cluster randomized controlled trial. Inst för folkhälsovetenskap/Dept of Public Health Sciences; 2012 Sep 18. |
|
Pham QD, Huynh TK, Luong TT, Tran T, Vu TX, Truong LX. HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, Vietnam. HIV clinical trials. 2013 Feb 1;14(1):34-44. |
|
Ãâ€ÃÂàØèÕÒàÃÅ“, ÖãáãßÞÒ Ñ, âÕàÛØÚÑÃÂÕÒàÃÂ, ÑÕàØÚÞÒàÃÂ, ÃÂÛÕÃÂÞÒàÃÂ, ÑÕááâàÃÂèÃÂÞÒàï, ÃÂÚØÛìÖÃÂÃÂÞÒàÃÂ, àÃÂÃ¥ØÜÞÒàá. ÒûøÑÂýøõ ÒØç-øýфõúцøø ýð øÑÂхþôы ûõчõýøѠтуñõрúуûõ÷ð ø рð÷òøтøõ ûõúðрÑÂтòõýýþù уÑÂтþùчøòþÑÂтø. ÒõÑÂтýøú Úð÷ðхÑÂúþóþ ÃÂðцøþýðûьýþóþ üõôøцøýÑÂúþóþ уýøòõрÑÂøтõтð. 2014(2-4). |
|
ABEBE Y. SURVIVAL AND ITS DETERMINANT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS WITH HIV CO-INFECTION: St. PETER TUBERCULOSIS SPECIALIZED HOSPITAL ADDIS ABABA, ETHIOPIA (Doctoral dissertation, AAU). |
|
Heunis JC, Kigozi NG, Chikobvu P, Botha S, van Rensburg HD. Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health. 2017 Jan 6;17(1):38. |
|
Gesesew H, Tsehayneh B, Massa D, Gebremedhin A, Kahsay H, Mwanri L. Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia. Infectious Diseases of Poverty. 2016 Dec 5;5(1):109. |
|
Kadima JN, Mukanyangezi MF, Uwizeye CB. Effectiveness and safety of concurrent use of first-line antiretroviral and antituberculous drugs in Rwanda. Journal of tropical medicine. 2014 Jan 30;2014. |
|
Osman M, Seddon JA, Dunbar R, Draper HR, Lombard C, Beyers N. The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa. BMC public health. 2015 Jun 18;15(1):556. |
|
Furin J, Brigden G, Lessem E, Rich M, Vaughan L, Lynch S. Global progress and challenges in implementing new medications for treating multidrug-resistant tuberculosis. Emerging infectious diseases. 2016 Mar;22(3). |
|
O'Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Jacobs WR, Larsen MH. A novel reporter phage to detect tuberculosis and rifampin resistance in a high-HIV-burden population. Journal of clinical microbiology. 2015 Jul 1;53(7):2188-94. |
|
Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia. International Journal of Infectious Diseases. 2015 Oct 31;39:57-61. |
|
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 